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Background: In response to high burden of opioid abuse in Iran, Ministry of Health has launched a large-scale opioid maintenance 
treatment program, delivered through a network of certified drug treatment centers. To promote opioid pharmacotherapies, there is an 
urgent need to develop and introduce evidence-based psychosocial interventions into the network.
Patients and Methods: This is a randomized clinical trial (RCT) to investigate feasibility and effectiveness of adding mindfulness-based 
group therapy to opioid pharmacotherapies as compared to opioid pharmacotherapies alone. The primary outcomes were treatment 
retention and percentage of weekly morphine, methamphetamine, and benzodiazepine negative tests.
Discussion: This is the first RCT that explores the effectiveness of mindfulness-based relapse prevention group therapy among opioid 
dependent clients in Iran. The feasibility of group therapy and comparison of outcomes in intervention and control groups should be 
discussed in the outcome article.
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1. Introduction
Iran has a long and hard-to-control border with Afghan-
istan, the main producer of illegal opiates in the world. 
Across this border opioid drugs are smuggled into the 
luxurious drug markets of European countries (1). Ac-
cording to a national epidemiologic study conducted by 
Ministry of Health, there are more than 1.2 million opioid 
dependents in the country (2). A more recent study esti-
mated the number of drug dependents by indirect meth-
ods at 1.2 million that most of them were opioid users (3). 
A rapid change in opiate use patterns during recent years 
from opium to heroin and from smoking to injection has 
made the opioid dependence epidemic more problem-
atic (4). Using unsterile syringe and injection equipment 
is the most prevalent route (69.2%) of HIV transmission 
among all registered HIV positive cases (5). To respond to 
HIV epidemic among people who inject opioid, the meth-
adone maintenance treatment was launched in 2002 and 
scaled up rapidly across the country.
Currently, opioid maintenance, treatment programs, 
and short-term medically assisted withdrawals are de-
livered through a network of certified drug treatment 
centers. Furthermore, opioid maintenance treatment 
could successfully decrease cue-induced cravings among 
opioid users (6), however, they are less effective in reduc-
ing stress-induced cravings (7). Hypothetically, new ap-
proaches of psychotherapies that focus on mindfulness 
and acceptance might enhance anti-craving properties of 
opioid maintenance treatment through reducing stress-
induced cravings. Mindfulness-based therapies are new 
approaches in psychotherapy that integrate spiritual 
traditions such as mindfulness meditation with classic 
behavioral therapy approaches (8). Mindfulness helps 
clients to learn how to monitor their own mental pro-
cesses free of judgment and without being caught up 
in the actual content of their thoughts. The core skill in 
mindfulness is the capacity to respond to aversive cogni-
tions, sensations, and emotions with greater acceptance, 
present moment awareness, and a nonjudgmental atti-
tude (9). Through mindfulness practices, the content of 
the thought becomes less important than the extent of 
the individual’s awareness and reaction to it and its oc-
currence (9).
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 Mindfulness-based therapies have proved to be effective 
in a wide range of physical and psychological problems 
such as chronic pain (10), depression, anxiety, and stress 
among college students (11) or people with subarachnoid 
hemorrhage (12), psychosocial stress (13), and depression 
(14), as well as distinct psychiatric disorders, including 
hypochondriasis (15), social phobia (16), generalized anxi-
ety disorder (17), obsessive-compulsive disorders (18), and 
somatization disorder (19). Mindfulness-based relapse 
prevention (20) is a program integrating mindfulness 
meditation practices with traditional relapse preven-
tion (RP). The program was tested and proved its effects 
in decreasing relapses in different groups of drug users, 
(21). Similar mindfulness-based programs for substance 
abuse have been shown to increase compliance, cogni-
tive control, regulation of emotions, and reduce stress in 
alcohol dependents (22, 23) as well as some other similar 
influences (24).
The effectiveness of mindfulness in different popula-
tions of drug users suggests that more trials (in which 
the type of ‘Mindfulness-based Group Therapy’ was clear-
ly defined and described) were required to establish the 
efficacy of Mindfulness-based Group Therapy for opioid 
dependence treatments.
2. Patients and Methods
This study was a pilot, randomized, parallel group, one 
to one controlled trial investigating feasibility, accept-
ability and effectiveness of mindfulness-based group 
therapy to improve treatment outcomes in opioid depen-
dent clients.
2.1. Inclusion Criteria
The opioid dependent clients receiving treatment as 
usual in Iranian National Center for Addiction Studies 
(INCAS) were randomly assigned to intervention and 
control groups. INCAS Clinic is located in southwest of 
Tehran, Iran and provides assisted withdrawal and main-
tenance treatment with opioid agonist medications, in-
cluding methadone and buprenorphine for its opioid 
dependent clients (96.6% male). Inclusion criteria were 
as follows: (1) diagnosis of opioid dependence according 
to DSM-IV-TR criteria, (2) age range 18 to 40 years, (3) at 
least 8 years of completed education (5), stabilization on 
medical treatment (4),  and informed written consent 
for participation in the study. The exclusion criteria were 
psychosis, dementia, imminent suicide risk, organic 
brain disorders, diagnosis of other drug dependence 
(except nicotine), or non-stabilization on 2-week medical 
treatments.
2.2. Content of the Interventions
Intervention was a combination of 8-session mindful-
ness-based group therapy developed by Bowen et al. and 
the usual treatment provided to opioid dependents in 
INCAS clinic (Figure 1). The study was designed in a man-
ner to be comparable to other studies of mindfulness-
based group therapy for addiction treatment. There was 
an English manual available to deliver the intervention 
(20), which described it as a structured intervention. 
One of the authors translated the manual to Farsi, which 
was edited by an addiction expert with a PhD in clinical 
psychology. The therapy sessions held in a closed-group 
format and conducted on a weekly basis. Each session 
lasted 120 minutes. It was a structured intervention with 
a predefined title and content for each session, and the 
sessions were kept in sequence. Table 1 outlines an over-
view of the topics and themes that were covered in each 
session. Although each session had a central theme, the 
sessions were intended to build upon previous week’s 
practices.
Recruitment of opioid dependent 
clients from INCAS clinic  
Baseline Assessment  
Randomization 
Control  Mindfulness-based Group Therapy 
Combination of 8 weekly sessions 
of Mindfulness-based Relapse 
Prevention (MBRP) Group 
Therapy and treatment as usual
Treatment as usual
 
Final Assessment 
Figure 1. Consort Diagram of the Study
Table 1. Mindfulness-based Relapse Prevention Group Therapy 
Sessions
Session Central Theme
1 Automatic pilot and relapse
2 Awareness of triggers and cravings
3 Mindfulness in daily life
4 Mindfulness in high risk situations
5 Acceptance and skillful actions
6 Seeing thoughts as thoughts
7 Self-care and lifestyle balance
8 Social support and continuing practice
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Table 2. Assessment Instruments Proposed for the Current Study
Instrument Baseline Weekly 8 Weeks Follow up
Log sheet of treatment participation √
Urine drug testing for morphine, methamphetamine, and benzodiazepines √ √ √
Addiction Severity Index (26) √ √
Alcohol and drug cravings (27) √ √
DASS-21 (19) √ √
Mindfulness (28) √ √
Acceptance (8) √ √
All study participants received medical treatment 
through opioid agonist medications in outpatient INCAS 
clinic according to national protocols (25). The metha-
done or buprenorphine administration was conducted 
through regular visits by certified physicians that were 
more frequent during the first week of treatment and 
gradually decreased to at least one visit per week. Clients 
who received maintenance treatment should have come 
to the clinics for daily supervised dosing during the first 
two months of treatment. The take-home doses were al-
lowed 1 d/wk from the beginning of the third month, 
which could increase from 1 d/mon to at most 6 d/wk con-
tingent to appropriate compliance and negative weekly 
urine tests for morphine and methamphetamine. The 
baseline, weekly, and end of the treatment study assess-
ments are presented in Table 2.
2.3. Sample Size Calculation
The study participants recruited in INCAS in the autumn 
of 2013. Thirty eligible individuals were selected random-
ly for participation in the study; 15 of them were assigned 
to each intervention group. In order to have consistency 
in seasonality across assessment points, the assessment 
obtained in the autumn of 2013 served as the baseline or 
pretest assessment point for the main substantive inter-
vention outcome analysis and the winter of 2013 assess-
ment served as the outcome time point for the analysis 
report; hence, this was an experimental research design.
2.4. Statistical Analysis
To determine legitimate numerical codes, data clean-
ing was performed by both graphical and descriptive sta-
tistics to ensure data accuracy, check out-of-range values 
for categorical variables, and make sure that mean and 
standard deviations were within the plausible ranges 
for continuous composite variables (29). The patterns 
of missing data were checked regarding how much and 
why they were missing. Results of SPSS MVA (missing 
values analysis) using t test (α = 0.05) for outcome com-
posite variables were checked to ensure that patterns of 
missing data in outcome variables were not related to 
population’s demographic variables such as sex, area of 
residency, and group (intervention vs. condition). Distri-
bution of scores on continuous variables was checked 
for univariate (P < 0.001) and multivariate normality 
using LISREL, version 8.72 (30). T test and chi-square test 
were conducted to match the intervention and control 
groups with respect to demographic variables. Repeat-
ed measure analysis of variance was used to test the ef-
fectiveness of mindfulness-based group therapy in the 
study population.
3. Discussion
To the best of our knowledge, this is the first study to 
test the acceptability and efficacy of ‘Mindfulness-based 
Group Therapy’ versus ‘Treatment as Usual’ for opioid de-
pendent clients in Iran. There are some potential limita-
tions regarding the present study that merit discussion. 
One potential concern is the random assign of the par-
ticipants to their study condition, which may lead to re-
alize whether or not they are receiving the added group 
therapy. When the participants prefer one group to the 
other, this might disappoint them, which may negatively 
affect the treatment outcome. However, since the study 
intended to investigate the effect of adding the mindful-
ness-based group therapy to treatment as usual, the cur-
rent design remains most appropriate as it is closer to a 
real world situation. After the mindfulness-based group 
therapy session, the study participants were advised to 
report their participation in self-help programs during 
the course of the therapy. As it is not possible to moni-
tor participants’ behavior during this period, self-reports 
about their use of other treatment programs should be 
trusted. Throughout the recruitment, the mindfulness-
based group therapy sessions and its follow-ups, it was 
emphasized to the participants that their honest infor-
mation was crucial and there would be no consequences 
if they participated in other methods. It is hoped that by 
conveying this message to the participants, they were 
motivated to cooperate throughout the study and pro-
vide their honest reports about their experiences dur-
ing study assessments. The results of the present study 
indicate whether mindfulness-based group therapy can 
improve the outcome of opioid dependence treatment in 
the context of Iran drug treatment services.
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